| 臺大學術典藏 |
2018-09-10T06:12:17Z |
In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood
|
Lu, D.T.-C. and Chang, S.-C. and Chen, Y.-C. and Luh, K.-T. and Hsieh, W.-C.; SHAN-CHWEN CHANG; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-09-29T01:48:27Z |
In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood
|
Lu D.T.-C.;Chang S.-C.;Yee-Chun Chen;Luh K.-T.;Hsieh W.-C.; Lu D.T.-C.; Chang S.-C.; YEE-CHUN CHEN; Luh K.-T.; Hsieh W.-C. |
| 臺大學術典藏 |
2018-09-10T04:06:34Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, S.-J. and Teng, L.-J. and Hsueh, P.-R. and Ho, S.-W. and Luh, K.-T.; PO-REN HSUEH |
| 國立臺灣大學 |
2002 |
In Vitro Activities of Antimicrobial Combinations against Clinical Isolates of Stenotrophomonas Maltophilia
|
廖淑貞; 鄧麗珍; 何憲武; 陸坤泰; 薛博仁; LIAW, SHWU-JEN; TENG, LEE-JENE; HO, SHEN-WU; LUH, KWEN-TAY; HSUEH, PO-REN |
| 國立臺灣大學 |
2002-07 |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw, SJ; Teng, LJ; Hsueh, PR; Ho, SW; Luh, KT. |
| 臺大學術典藏 |
2020-03-27T05:31:05Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Luh K.-T.; PO-REN HSUEH; Ho S.-W.; Teng L.-J.; Liaw S.-J.; Luh K.-T.;Ho S.-W.;PO-REN HSUEH;Teng L.-J.;Liaw S.-J. |
| 臺大學術典藏 |
2002 |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw S.-J.; LEE-JENE TENG; Hsueh P.-R.; Ho S.-W.; Luh K.-T.; Liaw S.-J.;Lee-Jene Teng;Hsueh P.-R.;Ho S.-W.;Luh K.-T. |
| 臺大學術典藏 |
2020-07-01T08:45:22Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Shwu-Jen Liaw;Teng L.-J.;Hsueh P.-R.;Ho S.-W.;Luh K.-T.; SHWU-JEN LIAW; Teng L.-J.; Hsueh P.-R.; Ho S.-W.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-18T08:40:04Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw S.-J.;Teng L.-J.;Po-Ren Hsueh;Ho S.-W.;Luh K.-T.; Liaw S.-J.; Teng L.-J.; PO-REN HSUEH; Ho S.-W.; Luh K.-T. |
| 臺大學術典藏 |
2021-05-26T03:35:08Z |
In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia
|
Liaw S.-J.; Teng L.-J.; Hsueh P.-R.; Ho S.-W.; KWEN-TAY LUH |
| 臺北醫學大學 |
2004 |
In Vitro activities of B-lactam antibiotics alone and in combination with sulbactam against gram-negative bacteriae
|
李文生; Wang FD; Lin ML; Lee WS; Liu CY |
| 臺大學術典藏 |
2020-03-27T05:28:25Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
PO-REN HSUEH; Liao C.-H.; Tsuji M.; Huang Y.-T.; Lee Y.-J.; Hsueh S.-C.; PO-REN HSUEH;Tsuji M.;Liao C.-H.;Huang Y.-T.;Lee Y.-J.;Hsueh S.-C. |
| 臺大學術典藏 |
2020-12-18T08:37:00Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
Hsueh S.-C.;Lee Y.-J.;Huang Y.-T.;Liao C.-H.;Tsuji M.;Po-Ren Hsueh; Hsueh S.-C.; Lee Y.-J.; Huang Y.-T.; Liao C.-H.; Tsuji M.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-18T05:56:32Z |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
|
Hsueh S.-C.; Lee Y.-J.; YU-TSUNG HUANG; Liao C.-H.; Tsuji M.; Hsueh P.-R. |
| 國立成功大學 |
2023 |
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveil
|
Lee, Y.-L.;Ko, W.-C.;Hsueh, P.-R. |
| 臺大學術典藏 |
2018-09-10T08:05:53Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Jean, S.-S. and Hsueh, P.-R. and Lee, W.-S. and Chang, H.-T. and Chou, M.-Y. and Chen, I.-S. and Wang, J.-H. and Lin, C.-F. and Shyr, J.-M. and Ko, W.-C. and Wu, J.-J. and Liu, Y.-C. and Huang, W.-K. and Teng, L.-J. and Liu, C.-Y.; PO-REN HSUEH; LEE-JENE TENG |
| 臺大學術典藏 |
2020-03-27T05:29:58Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Liu C.-Y.; Teng L.-J.; Huang W.-K.; Liu Y.-C.; Liu C.-Y.;Teng L.-J.;Huang W.-K.;Liu Y.-C.;Wu J.-J.;Ko W.-C.;Shyr J.-M.;Lin C.-F.;Wang J.-H.;Chen I.-S.;Chou M.-Y.;Chang H.-T.;Lee W.-S.;PO-REN HSUEH;Jean S.-S.; Jean S.-S.; PO-REN HSUEH; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J. |
| 臺大學術典藏 |
2020-06-30T06:13:31Z |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Jean S.-S.;Hsueh P.-R.;Lee W.-S.;Chang H.-T.;Chou M.-Y.;Chen I.-S.;Wang J.-H.;Lin C.-F.;Shyr J.-M.;Ko W.-C.;Wu J.-J.;Liu Y.-C.;Huang W.-K.;Lee-Jene Teng;Liu C.-Y.; Jean S.-S.; Hsueh P.-R.; Lee W.-S.; Chang H.-T.; Chou M.-Y.; Chen I.-S.; Wang J.-H.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; LEE-JENE TENG; Liu C.-Y. |
| 臺大學術典藏 |
2010 |
In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: Nationwide data from the SMART Programme
|
Wang J.-H.; Chen I.-S.; Chou M.-Y.; Chang H.-T.; Lee W.-S.; PO-REN HSUEH; Jean S.-S.; Jean S.-S.;Po-Ren Hsueh;Lee W.-S.;Chang H.-T.;Chou M.-Y.;Chen I.-S.;Wang J.-H.;Lin C.-F.;Shyr J.-M.;Ko W.-C.;Wu J.-J.;Liu Y.-C.;Huang W.-K.;Teng L.-J.;Liu C.-Y.; Lin C.-F.; Shyr J.-M.; Ko W.-C.; Wu J.-J.; Liu Y.-C.; Huang W.-K.; Teng L.-J.; Liu C.-Y. |
| 臺北醫學大學 |
2008 |
In Vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over ten years.
|
劉永慶; Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC |
| 國立臺灣大學 |
2009 |
In Vitro Activities of Moxifloxacin and Tigecycline against Bacterial Isolates Associated with Intraabdominal Infections at a Medical Center in Taiwan, 2001-2006
|
劉佳穎; 路景蘭; 黃昱璁; 廖俊星; 薛博仁; LIU, CHIA-YING; LU, CHING-LAN; HUANG, YU- TSUNG; LIAO, CHUN-HSIN; HSUEH, PO-REN |
| 臺大學術典藏 |
2018-09-10T07:24:02Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu, C.-Y. and Lu, C.-L. and Huang, Y.-T. and Liao, C.-H. and Hsueh, P.-R.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:30:04Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
PO-REN HSUEH; Liao C.-H.; PO-REN HSUEH;Liao C.-H.;Huang Y.-T.;Lu C.-L.;Liu C.-Y.; Liu C.-Y.; Lu C.-L.; Huang Y.-T. |
| 臺大學術典藏 |
2020-12-18T08:38:50Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu C.-Y.; Lu C.-L.; Huang Y.-T.; Liao C.-H.; PO-REN HSUEH |
| 臺大學術典藏 |
2021-05-18T05:57:10Z |
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006
|
Liu C.-Y.; Lu C.-L.; YU-TSUNG HUANG; Liao C.-H.; Hsueh P.-R. |
